Luminex, Bio-Rad Extend Deal, Includes Magpix System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today announced the expansion of a global sales and distribution deal with Bio-Rad Laboratories to 2023 as well as the granting of the global sales and distribution rights for the Magpix multiplexing platform.

Under the terms of the agreement Bio-Rad will offer Luminex's xMAP systems, including the Magpix system, which detects up to 50 different analytes on a single sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.